This is a preview of subscription content, access via your institution.
Reference
Williams T, et al. A case of recurrent anaphylaxis to honey bee venom immunotherapy with omalizumab used as a premedication. Internal Medicine Journal 48 (Suppl. 6): 18 (plus poster) abstr. P46, Nov 2018. Available from: URL: http://doi.org/10.1111/imj.46_14077 [abstract] - Australia
Rights and permissions
About this article
Cite this article
Bee venom allergy immunotherapy. Reactions Weekly 1732, 82 (2018). https://doi.org/10.1007/s40278-018-55538-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-55538-x